IRVINE, Calif.–(BUSINESS WIRE)–Mar. 17, 2016–
Masimo
(NASDAQ: MASI) announced today that a new study reported on the accuracy
of Masimo’s Blue® sensors as compared to Nellcor and Masimo Standard
sensors for cyanotic children with blood oxygen saturation less than 85%.1
Masimo’s Blue sensor was designed specifically for cyanotic infants and
children with congenital heart disease.

The study was performed at the Lucile Packard Children’s Hospital at
Stanford University with the aim of determining, in children with
cyanotic congenital heart disease, which of three different pulse
oximeter sensors is the most accurat…

Más información: New Study Reports on Accuracy of Masimo’s Blue® Sensors at Saturations below 85% in Children with Cyanotic Congenital Heart Disease